Ephedrine hydrochloride - Aguettant Ltd
Aguettant
Description
A non-specific adrenoceptor agonist.
For reversible airway obstruction by mouth
Adult: 15–60 mg 3 times a day.
Nasal congestion, sinusitis affecting the maxillary antrum by intranasal administration
Child 12-17 years: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril, administer ephedrine 0.5% nasal drops.
Adult: Apply 1–2 drops up to 4 times a day as required for a maximum of 7 days, to be instilled into each nostril.
Indications
For the management of reversible airways obstruction.
Ephedrine is less suitable and less safe for use as a bronchodilator than the selective beta2 agonists, because it is more likely to cause arrhythmias and other side-effects. It should be avoided if possible.
Contraindications
Avoid use in the case of renal impairment, pregnancy and breast feeding.
Preparations Available
Solution for injection
Sizes Available
Solution for injection
30 mg/10 ml, 1 pre-filled syringe
30 mg/10 ml, 12 pre-filled syringes
More on: Bronchodilators , Other adrenoceptor agonists